Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
The safety of these medications for developing babies has not been established
Sodium-glucose cotransporter 2 inhibitors (SGLT2is) that have shown renal benefits should first be used to inhibit diabetic kidney disease (DKD) progression in patients with albuminuria or a reduced eGFR
Clinical research has evaluated doses up to 12 mg per week, depending on individual tolerance and treatment goals
10.1530/eje.1.02221 64 SainiK.SharmaS.KhanY
US$ 21.54
US$ 20.64
US$ 25.60
US$ 22.10
US$ 20.15
US$ 24.63
